Navigation Links
DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
Date:3/18/2011

SAN ANTONIO, March 18, 2011 /PRNewswire/ -- Garrett Mann filed suit today against Johnson & Johnson, Inc. and DePuy Orthopaedics, Inc. seeking compensation for injuries caused by the failure of the DePuy ASR XL Acetabular Hip Replacement System that has been recalled.  John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Mr. Mann in the lawsuit filed in the United States District Court for the Western District of Texas in San Antonio, Texas.

On January 28, 2009, Garrett Mann underwent hip replacement surgery.  A DePuy ASR XL Acetabular System with a DePuy S-ROM femoral stem was implanted in his right hip.  The DePuy ASR XL Acetabular System failed prematurely, creating serious pain and injuries for Mr. Mann and increasing the risk for early revision surgery in the future.

"It is devastating for a thirty year old to face the prospects of a failed hip device," said attorney John David Hart.  "The DePuy Orthopaedics ASR XL Acetabular Hip Replacement System has harmed thousands of patients, from young adults to seniors.  Failure of this recalled hip replacement system has a lifetime of consequences for patients of all ages."

DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular hip replacement system may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage. This device was marketed by DePuy Orthopaedics as a high performance hip replacement system.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs, automobile and truck accidents and oil and gas litigation. For more information, please contact John Hart at 800.961.4278 or johnhart@hartlaw.com.


'/>"/>
SOURCE Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
2. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
3. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
4. DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
5. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
6. Chesley Files Class Action Against DePuy Orthopaedics
7. Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
8. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
9. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
10. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
11. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... 29, 2017 In a move that promises ... compliance for veterinary practices of all sizes, Cubex LLC ... that makes TITAN,s expertise in physical security, drug diversion ... clients nationally. ... controlled substances is at risk today," said TITAN founder ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two ... in excess of $835 million in resolved debt for its clients. , Credit card ... of the categories of debt settled by the company. With more than a decade ...
(Date:9/19/2017)... ... September 19, 2017 , ... Arizona-based ... as the President of its HealthBI division. McFarland will grow the organization’s ... , “Scott is a utility player who balances his day as a ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a new ... we’re born, Nature gives us a full supply of melanin – in the back ... this natural glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown ...
(Date:9/19/2017)... ... September 19, 2017 , ... Presenting its annual ... (SPBA) hosted “Expanding Your Success” with an educational emphasis. , The three-day ... best practices for third party administrators (TPAs) related to health plan management and ...
Breaking Medicine News(10 mins):